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The current project deals with designing and synthesizing of colourimetric chemosensors to detect the cations in the 
aqueous medium and biological sample. To achieve this goal a new series of quinazolinone derivatives have been 
synthesized via reaction of the novel 6-nitro-2-propyl-4H-benzo[d][1,3]oxazin-4-one 3 with selected nitrogen nucleophiles, 
namely, formamide, hydrazine hydrate, hydroxylamine hydrochloride, o-phenylendiamine, o-aminophenol and o-
aminothiophenol, urea and/or thiourea. Structures of the new compounds have been investigated depending on their spectral 
data (IR, 1H and 13C NMR and MS) and elemental analyses. Some of the newly synthesized products exhibit significant 
response as chemosensors for a few cations detection. 
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Currently, synthesis of colourimetric sensors for 
detecting of cations and anions is one of the 
researcher's targets in the organic synthesis 
fieldbecause of the prospect implementation of these 
chemosensors as diagnostic tools in medical, 
physiological and environmental applications1. 
Copper cation is the most abundant ion in the human 
body and several proteins utilize Cu2+ as a cofactor 
for the transfer of electrons in redox reactions. 
Biologically, excess Cu2+ in cells can stimulate the 
creation of reactive oxygen species and can harm 
lipids, DNA and RNA and cause some of the 
dangerous diseases, such as Dementia's disorder, 
Prion, Wilson and Menkes disease, which are 
directly related to the copper toxicity2. Also, Cd2+ is 
extremely poisonous to the living organism and its 
compounds pass in the environment from human 
activities or geological. Cadmium and its salts are 
classified as blacklist compounds because high 
exposure level of Cd2+ is associated to raise 
cardiovascular risks diseases, cancer, liver diseases 
and kidney disorder3. On the other hand, mercury is 
considered as the greatest harmful pollutant, which 
affects directly on human and environmental health, 
so assay of mercury ions in the environment is a 
significant target reference4. The most reports of 
sensing Hg2+ based on using atomic absorption 
spectrometry, Raman spectroscopy, inductively 
coupled plasma mass spectrometry, which is 
expensive and needs long time pre-treatment5. 
Various techniques such as electrochemical, atomic 
absorption, inductively coupled plasma atomic 
emission and piezoelectric quartz crystals6, have 
been used for notifying of metal ions but their 
utilization is limited due to its expensive equipment, 
laboratories and time consuming procedures. Lin 
et al. have applied a ratiometric fluorescent probe for 
Cu2+ determination7. Kato et al. used isotope dilution 
inductively coupled plasma mass spectrometry for 
the detection of silver copper, zinc, nickel, lead and 
cadmium in seawater8. Colourimetric techniques are 
the most favorable methods to their low cost, lack of 
equipment, rapid and we can detect it by naked eye9. 
Thus, development of colourimetric chemosensors 
depend on changing in absorption accompanied by 
sensible colour changes, for heavy metal ions has 
produced as an active area of valuable importance. 
Kim et al. showed a colourimetric sensor for the 




determination of Cd, Hg and Pb ions10. Li et al. 
utilized a turn-on fluorescent sensor for assay of 
Cd2+, Hg2+ and Zn2+ in water11. Fegade et al, showed 
selectivity of dualchannel chemosensor for copper in 
semiaqueous media12. In the last decade, several 
heterocyclic chemosensors were synthesized for the 
recognition of different ions13. Synthesized azo dye-
based heterocyclic chemosensors designed to 
produce fluorescent sensors for the detection of zinc 
without interference with cadmium14. Lu et al.15, 
designed a sensor containing naphthalimide as the 
fluorophore, which by undergoing two reverse ICT 
processes in sensing Zn2+ and Cd2+ distinguished 
between this ion pair proficiently.  
Quinazolinones have attracted notable interest 
in organic and medicinal chemistry due to their 
therapeutic potential such as anticancer, 
antibacterial, antidiabetic, hypnotic, sedative, 
analgesic, anticonvulsant, antitussive, anti-
inflammatory activities16. Few reports were 
performed for checking the sensor activity of 
quinazolinone derivatives. Ailin Yuan et al, 
synthesized novel quinazolinone compound as a 
fluorescence sensor for the ferric ion17. 
Quinazolinonebased sensors for amine vapors 
and Cu2+ ion18 have been developed. As an 
extension of our awareness in synthesis of 
quinazolinone heterocyclic, we report that some 
quinazolin-4(3H)-ones can be used as a simple 
and efficient ‘turn-on’ fluorescent chemosensor 
for a highly selective and sensitive detection of 
some cations, Cu2+, Hg2+ and Cd2+ in aqueous 
medium and biological sample. 
 
Results and Discussion 
As part of our concern in the organic synthesis of 
quinazolinone derivatives19 we produced a new 
chemosensor carrying quinazolinone moiety. As 
displayed in (Scheme I), 2-amino-5-nitrobenzoic  
acid 1 was reacted with butyryl chloride, in dry 
pyridine, to yield 2-(butyramido)-5-nitrobenzoic acid 
2. Microanalytical and spectral data were used for 
structure elucidation of the anilide 2. IR spectrum 
showed absorption bands at ν 1730 and 1640 cm−1 
which are characteristic for both C=O carboxylic acid 
and amide functions stretching vibration, respectively. 
1H NMR spectrum of the anilide 2 exposed two 
deuterium- exchangeable, protons at δ 8.95 and 11.80 
related to N–H and CO2H. Mass spectrum showedthe 
molecular ion peak at m/z 252 which is coincident 
with the prospective anilide formula. 
Using acetic anhydride,intramolecular cyclization 
for of the anilide 2 was performed leading to our 
target 6-nitro-2-propyl-4H-benzo[d][1,3]oxazin-4-one 
3 as a dynamic benzoxazinone moiety with 
electronically unsaturated character20. IR spectra of 
compound 3was very good indication for absence of 
both carboxylic and amide functions. On the other 
hand, a characteristic absorption band was observed at 
ν 1750 cm−1 signifying C=O function of 3,1-
benzoxazin-4-ones. Mass spectrum gave a molecular 
ion peak at m/z 234 which is matching with the 
predictable molecular formula acquired through 
loosing of one molecule of water from the anilide 2. 
These results are deemed confirmatory for the 
postulation that cyclization process implicated both 
carboxylic and amidic functions (Scheme I). 
Reaction of 6-nitro-2-propyl-4H-benzo[d][1,3] 
oxazin-4-one 3 with some selected nitrogen 
nucleophiles, namely, formamide, hydrazine hydrate, 
hydroxylamine hydrochloride, o-phenylendiamine, o-
aminophenol, o-aminothiophenol, urea and/or 
thiourea furnished a variety of 4(3H)-quinazolinones 
4-14 via aminolysis at position 3 (Scheme II). It is 
expectant that the reactions managed through 
nucleophilic ring opening ring closure (RORC) 
process accompanied by ring oxygen replacing with 
nitrogen. Oxazinone ring splitting takes place by the 
attack of nitrogen nucleophile followed by cyclization 
on the highly electrophilic sp2 hybridized carbonyl 





Scheme I — 6-Nitro-2-propyl-4H-benzo[d][1,3]oxazin-4-one 3 




Fusion of the benzoxazinone 3 with extra amount 
of formamide afforded 6-nitro-2-propylquinazolin-
4(3H)-one 4. Structure of compound 4 was elucidated 
from its correct elemental analysis together with its IR 
spectrum which showed strong absorption bands at ν 
3280, 3150, 1670 and 1622 cm—1 related to NH 
(bonded and non-bonded), C=O and C=N, 
respectively. Quinazolinone 4 showed, in solution, 
lactam–lactim dynamic equilibrium. In polar solvents, 
the lactam form is more predominant than the lactim 
one, hence with decreasing the solvent polarity, the 
lactim form becomes more predominant22. 
The existence of compound 4 in the lactam-lactim 
tautomeric equilibrium was demonstrated via its 
reaction with acetic anhydride where it undergoes N-
acetylation (through the lactam form) to yield 
compound 3-acetyl-6-nitro-2-propylquinazolin-4(3H)-
one 5, but, it upon alkylation with ethyl chloroacetate 
the ester ethyl 2-(6-nitro-2-propylquinazolin-4-
yloxy)acetate 6 was produced (through the lactim 
form) (Scheme II). The 1H NMR spectra of 
compounds 5 and 6 afforded signals at δ 2.10 ppm for 
three protons related to compound 5 acetyl group 
(CH3-C=O) in addition to δ 1.20-1.30 and 4.00-4.10 
which proved the exitance of the ester group protons 
in compound 6 (3H, CH3-CH2-), (2H, -OCH2CH3. 
Aiming to expand the synthetic efficiency of our 
newly synthesized benzoxazinone 3, reaction with 
hydroxylamine hydrochloride was studied as 
convenient route to the synthesis of 3-hydroxy-6-
nitro-2-propylquinazolin-4(3H)-one 7. Structure of 
compound 7 was proved from its IR spectrum which 
showed strong absorption bands at ν 3530 and 
1680 cm−1 due to both (OH and C=O) groups, 
respectively. The 1H NMR spectrum showed the D2O 
exchangeable proton for the OH group at 11.50 ppm. 
Reactions of the ultimate compound 7 with acetic 
anhydride yielded 3-(acetyloxy)-6-nitro-2-
propylquinazolin-4(3H)-one 8 which is a convenient 
intermediate for various organic synthesis. Structure 
of compound 8 was proved from its IR spectrum 
which showed a notable absorption bands at υ 1614, 
1670 and 1725 due to C=N, C=O (amide) and C=O 
(ester) groups, respectively with the lake of υ OH 
band. Mass spectrum of both compounds 7 and 8 
exhibited their proposed molecular ion peaks at m/z 
249, 291 respectively as base peaks. 
The aforementioned findings prompted us to carry 
out the reaction of 3 with some additional N-
nucleophiles. So, reaction of compound 3 with an 
equimolar quantities of 1,4-N,N, 1,4-N,O and 1,4-N,S-
nucleophiles, namely, o-phenylendiamine, o-
aminophenol and o-aminothiophenol, furnished the 
corresponding 3-substituted aminoquinazolinones 9a-
c. 1H NMR spectra of products 9a-c exhibited the 
integral count of seven aromatic protons at their 
characteristic chemical shift area. 13C NMR spectra of 
both compounds 9a-c confirmed the proposed 
structures exhibiting the expected count of carbon 
atoms. The mass spectrometry was an outstanding 
tool to demonstrate the suggested structures for 
compounds 9a-c showing their molecular ion  





Scheme II — Formation of quinazolinones 3 - 10 




In the same sense, equimolar remediation of 
compound 3 with 1,3-binnucleophiles such as urea 
and thiourea in boiling DMF furnished smoothly the 
anticipated quinazolinone derivatives 10a,b. 
Analytical and spectral data of these products were 
found in similarity with the proposed formula. IR 
spectra of both 10a,b compounds showed the C=O 
stretching vibrations at 1671, 1675 cm−1 and the C=S 
stretching vibrations at 1220-1050 cm−1 in addition to 
NH2 stretching vibrations at 3330, 3270 cm−1.The 
1H NMR spectra of compounds 10a,b demonstrated 
the appearance of the emergence of new singlet 
signals assigned to the characteristic NH2 groups 
protons at 6.2 and 6.5 ppm for both 10a and 10b, 
respectively. 1H NMR spectral data displayed a 
characteristic signal at δ 177.1 and 178.2 ppm 
attributed to both C=O and C=S carbons, respectively. 
In addition, mass spectrum represents a good guide to 
10a,b structure and showed the molecular ion peak at 
m/z 276 and 292 which corresponds to the suggested 
molecular formulas. 
Benzoxazinone 3 was reacted with hydrazine 
hydrate and /or phenyl hydrazine in boiling ethanol, 
3-amino-6-nitro-2-propylquinazolin-4(3H)-one 11a 
and 6-nitro-3-(phenylamino)-2-propylquinazolin-
4(3H)-one 11b were produced in a respective yield. 3-
Aminoquinazolinone 11a used as many-sided 
constructing bulk in synthetic heterocyclic chemistry. 
IR spectrum of the amine 11 exhibited a specific 
stretching bands at ν 3309 and 3212 cm−1 related to 
symmetric and asymmetric vibrations of NH2 group. 
The absorption bands due to C=O group, for ideal 
quinazolin-4-ones, was observed at ν 1673cm−1. 
These outcomes are in accordance with 1H NMR 
spectral data of compounds 11 which showed a broad 
singlets chemical shifts at δ 5.50 due to deuterium-
exchangeable protons of NH2. In addition, the mass 
spectra of compound 11a revealed its molecular ion 
peak at m/z 248 as base peak. All spectral data of 6-
nitro-3-(phenylamino)-2-propylquinazolin-4(3H)-one 
11b were fully consistent with its suggested formula 
(Scheme III). 
N-(6-nitro-4-oxo-2-propylquinazolin-3(4H)-
yl)acetamide 12 was obtained on refluxing of 
quinazolinone 11a with acetic anhydride. The IR 
spectrum of compound 12 revealed strong absorption 
bands assigned to C=N, two C=O group, NH and OH, 
respectively. 1H NMR spectrum of compound 12 
revealed that it exists in solution in a keto-enol 
tautomerism of an amide functionality, as it showed 
two singlet signals at δ 6.50 and 8.90 attributable to 
NH and OH of the keto and the enol forms, 
respectively. 
The carbothioamides 13 was targeted because of its 
expected biological activity23. Consequently, reacting 
of the amine 11a with carbon disulfide, in existence 
of sodium hydroxide as base catalyst and in situ 
methylation of the non-separable sodium 
dithiocarbamide salt, with the use of dimethyl sulfate, 
yielded Methyl(6-nitro-4-oxo-2-propylquinazolin-
3(4H)-yl)carbamodithioate 13. Structure of compound 
13 was elucidated from its IR spectrum which showed 
a strong absorption bands at 1450 and 1670 related to 
υ max C=S and C=O respectively and freed from the 
NH2 band. 1H NMR spectrum of the product showed a 




Scheme III — Synthesis of quinazolinones 11-14 




protons of SCH3. Mass spectrum exhibited a 
molecular ion peak at m/z 338, confirming the 
proposed molecular formula.The amine 11awas 
condensed with benzaldehyde to give the 
corresponding Schiff ’s bases 14 (Scheme III) which 
could be utilized as multilateral building bulk in a 
variety of heterocyclic synthesis. It will be of interest 
in our future project to discuss the behavior of 
azomethine 14 which includes an activated 
azomethine group (–N=CH)24. Spectral data of the 
product pointed to the disappearance of NH2 function, 
indicating its embodiment in the condensation 
reaction. IR spectra of compounds 14 showed a strong 
absorption bands at 1610, 1676; related to υ C=N and 
υ C=O, respectively in addition of lacking any 
absorption band due to NH2. 
1H NMR spectrum of the 
trio gave specific chemical shift signals of azomethine 
proton (N=C–H) observed at δ 8.80. Mass spectrum 
exhibited a molecular ion peak at m/z 336 as base 
peak, confirming the proposed structure. 
The FT-IR comparison of some of our newly 
synthesized chemosensor 7, 10b and 11a,b versus 
their related complexs 15, 16, 17 and 18 were 
identified as shown in the Table I. The FT-IR 
spectrum changes of our produced complexs confirm 
that our primary amine, carbonyl groups, thiocarbonyl 
and hydroxyl group are sharing in the binding with 
our targeted metal cations. 
 
Colourimetric Study 
The colourimetric study was applied for 2.5×10−5 M 
of all the synthesized compounds, which were prepared 
in DMF- water (1:10). As can be seen from (Table II), 
Compounds 3, 9b,c, 10a, 12, 13 and 14 did not give 
any changes of colour after adding all metals. The 
chemosensor 10b and 7 showed the colour change 
from colourless to yellow when adding Cd2+ ion and 
the intensity of colour was increased with the addition 
of Cd2+ ions. The chemosensors 11a,b exhibited 
notable colour change from pale yellow to green when 
adding Cu2+ ion which gets more colour intensity on 
further addition of Cu2+ cation. The same chemosensor 
exhibited a remarkable colour change to rose on 
interacting with Hg2+and the intensity of colour also 
increased with further addition of Hg2+ion cation. This 
important colour change of complex 7, 10b and 11a,b 
can be easily applied for detection Cu2+, Cd2+ and Hg2+ 
ions in an aqueous mediums and biological samples. 
 
UV-vis absorption spectroscopy study 
The absorption response of complexes 15, 16, 17 
and 18 were examined in the presence of different 
solvents, for instance, ethanol, dimethylformamide, 
acetonitrile and. The chemosensor 7, 10b, 11a,b 
displayed good absorption intensity in the 
dimethylformamide solution contrast to other solvents 
and so we used dimethylformamide as a solvent for 
all UV-Vis spectral studies because it showed good 
absorbance shift and absorption intenisty25. Metal ions 
were prepared as aqueous solutions of 0.02 M nitrate 
salts in distilled water. Chemosensor stock solutions 
of 7, 10b, 11a,b (0.02 M) were dissolved in 
dimethylformamide. By using a micropipette, we 
prepared and diluted various concentrations of metal 
 
Table I — FT-IR variation between chemosensors and formed complexes 
Functional group Chemosensor number Stretching vibration chemosensor 
(cm–1) 
Complex Stretching vibration complex 
(cm–1) 
(C=O) 7 1680 15 1609 
(OH) 3530 3403 
(C=O) 10b 1671 16 1620 
(NH2) 3330 and 3270 3000 and 3100 
(C=O) 11a 1673 17 1615 
(NH2) 3309 and 3212 3290 and 3190 
(C=O) 11b 1675 18 1630 
(NH) 3360  3265  
 
Table II — Colourimetric responses of selected chemosensors toward various cations 
Chemosensor Detected cation Colourimetric Responses 
7 Cd Colourless to yellow 
10b Cd Colourless to yellow 
11a Cu Pale yellow to green 
Hg Pale yellow to rose 
11b Cu Pale yellow to green 
Hg Pale yellow to rose 
9b,c, 10a, 12, 13, 14 All cations No response 
 




ions to 2.5×10−5 M with the same solution. The 
diluted chemosensors were added to various 
concentrations of metal ions. The complex 17-Cu2+ 
showed the main absorption peak (λ max) at 345 nm. 
The complex 17-Hg2+ showed λ max at 495 nm. The 
complex 18-Cu2+ showed λ max at 360 nm. The 
complex 18-Hg2+ λ max at 505 nm. The complex 15-
Cd2+ showed λ max at 362 nm, the complex 16-
Cd2+displayed λ max at 425 nm. The calibration 
curves established standard concentrations of ions and 
specific absorbance for each one (Figure 1). 
 
Suggested Mechanism 
According to UV-Vis absorption analysis and the 
FT-IR spectrum of compounds 7, 10b and 11a,b 
towards their complexes 15, 16, 17 and 18 respectively, 
the binding positions were labeled in chemosensor 7, 
10b and 11a,b. Some predictable observations can be 
inferred. The variations in the FT-IR frequencies of 17 
and 18 suggest the primary or secondary amine and 
carbonyl groups are participating in the binding with 
metal ions and an established binding mechanism is 
shown in Table III. In the aqueous medium, the 
nucleophile chemosensors 11a,b attacked cations by 
lone pairs of electrons from amino and carbonyl groups 
to form five-membered ring which have high stability 
and a low amount of ring strained26,27. The change of 
the FT-IR frequencies of complex 16 indicates that 
Cd2+ coordinated with oxygen atom of carbonyl group 
and C=S group which inform binding mechanism was 
presented in Table III. Complex 15 have clearly 
observed shifts of FT-IR spectrum Table I, which 
indicated the formation of a binding mechanism, is 
shown in Table III. The nucleophile chemosensor 7 
attacked cations by lone pairs of electrons from OH 
and C=O groups to form a five-member ring26. 
 
Application of chemosensor in biological and 
environmental water samples 
The main purpose of the current study was to 
detect ions traces in a biological sample, so samples 
were collected from the medical laboratory in Al-zulfi 
hospital. The relationship between absorption and 
concentration was obtained by the calibration curve 
and a linear relationship was established to the 
determination of the concentration of Cu2+, Cd2+ and 
Hg2+ ions in the various blood samples. All blood 
samples were also further assayed by Atomic 
Absorption Spectroscopy (AAS) to show the 
chemosensor sensitivity. The synthesized 
chemosensors 7, 10b and 11a,b were carried as strip 
paper and added one drop of ion analyte to the 
chemosensor strip which directly detects the 
concentration of cation. 
 
Experimental Section 
Melting points were measured on an Optimelt 




Figure 1 — Calibration curves of absorbance intensity of different concentrations of ions 




The IR spectra were recorded on a Perkin−Elmer 
1800 Series FTIR spectrometer. Samples were 
analyzed as thin films on KBr plates. 1H and 13C NMR 
spectra were recorded at room temperature in base-
filtered DMSO-d6 on a Varian spectrometer operating 
at 400 MHz for proton and 100 MHz for carbon 
nuclei. Elemental microanalyses were recorded on a 
Perkin−Elmer series II CHNS analyzer 2400. Mass 
spectra were obtained using GCMS (QP-1000EX) 
Shimadzu gas chromatography instrument mass 
spectrometer (70 eV). 
 
2-(Butyramido)-5-nitrobenzoic acid, 2 
Butyryl chloride (1.06 g, 10 mmol) was portion-
wise added to a stirred solution of 2-amino-5-
nitrobenzoic acid (1.8 g, 10 mmol), in dry pyridine 
(30 mL) during 30 min. The mixture was stirred at RT 
for 2 h then poured into ice-cold water (200 mL), 
 
Table III — Proposed binding mechanism of different chemosensors 
Chemosensor λ max Complex structure Suggested binding mechanism 
18-Cu2+ 345 nm 
  
 
18-Hg2+ 495 nm 
  
 








17-Hg2+ 505 nm 
  
 










acidified with hydrochloric acid (2N) up to complete 
precipitation. The crude solid product was filtered off, 
washed thoroughly with cold water and crystallized 
from benzene to give compound 2 (2 g, 80%), yellow 
crystals, m.p.130-135°C. IR (KBr): 3300 (O–H, N–
H), 3010 (C–Harom), 2975, 2985 (C–Haliph), 1730 
(C=Ocarboxylic), 1640 (C=Oamidic), 1615 cm
−1 (bending 
N–H); 1H NMR (CDCl3): δ 1.90 (t, 2H, -CH2-CH2-
CH3), 1.50 (m, 2H, -CH2Me) and 1.20 (t, 3H, -CH3), 
7.20-8.70 (m, 3H, Harom), 8.95 (bs, 1H exchangeable 
with D2O, NH), 11.80 (bs, 1H exchangeable with 
D2O, OH);
 13C NMR (100 MHZ): δ 143.3 (C-1), 
115.15(C-2), 129.7 (C-3), 122.4(C-4), 132.98(C-5), 
121.52 (C-6), 168.1 (C-7COOH),  
170.2 (C-8NHC=O), 35.1 (C-9), 19.0 (C-10), 13.2 (C-
11); MS: m/z 252(M
+,70),253 (M+1,80). Anal. Calcd 
for C11H12N2O5 (252): C, 52.38; H, 4.80; N, 11.11; O, 
31.72. Found: C, 52.50; H, 4.95; N, 31.94%. 
 
6-Nitro-2-propyl-4H-benzo[d][1,3]oxazin-4-one, 3 
The dry solid anthranilide (2.52g, 10 mmol) 2 was 
treated with freshly distilled acetic anhydride until 
being pasted and then heated over water bath for 2 h 
before lifting to cool. The separated out solid was 
filtered off and recrystallized from light petroleum 
ether 40/60 affording the benzoxazinone 3 (2 g,85%), 
pale yellow crystals, m.p.185°C. IR (KBr): 3050 (C-
Haromatic), 2971, 2929,2881 (C-Haliphatic),1710(C=O), 
1617(C=N),1159 cm−1 (C-O-C); 1H NMR (400 MHZ, 
DMSO-d6): δ 2.10(2H, -CH2-CH2-CH3), 1.60 (m, 2H, -
CH2Me) and 1.10 (t, 3H, -CH3), 7.3-8.2 (m, 3H, Ar-
H);13C NMR (100 MHZ): δ 155.2 (C-1C=N), 159.1 (C-
2C=O), 120 (C-3), 128 (C-4), 127.4 (C-5), 133.5 (C-6), 
122 (C-7), 147 (C-8), 25.1 (C-9), 14.6 (C-10), 13.9 (C-
11); MS: m/z 234 (M+,20), 235(M+1,18). Anal. Calcd 
for C11H10N2O4 (234): C, 56.41; H, 4.30; N, 11.96. 
Found: C, 56.50; H, 4.47; N, 11.99%. 
 
6-Nitro-2-propylquinazolin-4(3H)-one, 4 
A solution of benzooxazinone derivative 3 (2.34 g, 
10 mmol,) in formamide (15 mL) was refluxed for 
2 h, left to cool, then poured into ice. The crude solid 
product was collected by filtration, dried and 
recrystallised from ethanol to give 4 (1.75g,75%), 
yellow crystals, m.p. > 300°C. IR (KBr): 3372, 3280 
(NH), 1670(C=O), 1622 cm−1 (C=N); 1H NMR (400 
MHZ, DMSO-d6): δ 2.30(2H, -CH2-CH2-CH3), 1.80 
(m, 2H, -CH2Me) and 1.22 (t, 3H, -CH3), 7.82-8.90 
(m, 3H, Ar-H), 9.40 (s, 1H, NH, D2O exchangeable);
 
13C NMR (100 MHZ): δ 155.2 (C-1), 164 (C-2), 123 
(C-3), 130.5 (C-4), 127.4 (C-5), 133.5 (C-6), 122 (C-
7), 148.8 (C-8), 25.4 (C-9), 14.6 (C-10), 13.7 (C-11); 
MS: m/z 233(M+,30), 234(M+1,23). Anal. Calcd for 
C11H11N3O3 (233): C, 56.65; H, 4.75; N, 18.02. 
Found: C, 56.80; H, 4.90; N, 18.40%. 
 
3-Acetyl-6-nitro-2-propylquinazolin-4(3H)-one, 5 
A solution of 4 (2.33 g, 10 mmol) in 20 mL acetic 
anhydride was refluxed for 4 h. The reaction mixture 
was then allowed to stand at RT for 2 h. The 
separated solid product was washed with water 
(2×100 mL), dried and crystallized from ethanol to 
afford compound 5 (1.65 g, 60%), pale-yellow 
crystals, m.p.135-7°C. IR (KBr): 1663 (C=OAcetyl), 
1675 (C=OQuinazolinone), 1622 cm
−1 (C=N); 1H NMR 
(400 MHZ, DMSO-d6): δ 2.40 (s, 3H, CH3-C=O), 2.00 
(2H, -CH2-CH2-CH3), 1.85 (m, 2H, -CH2Me), 1.10 (t, 
3H, -CH3), 7.55- 7.83 (m, 3H, Ar-H); 
13C NMR (100 
MHZ): δ 163.1 (C-1), 166.9 (C-2), 129.2 (C-3), 131.8 
(C-4), 121.5 (C-5), 136.1 (C-6), 124.0 (C-7), 146.2 
(C-8), 23.1 (C-9), 13.4 (C-10), 13.4 (C-11), 175.1 (C-
12C=O acetyl), 20.3 (C-13CH3CO); MS: m/z 275 (M
+,10), 
276 (M+1,33). Anal. Calcd for C13H13N3O4 (275): C, 
56.72; H, 4.76; N, 15.27. Found: C, 53.85; H, 4.90; N, 
15.40%. 
 
Ethyl 2-(6-nitro-2-propylquinazolin-4-yloxy)acetate, 6 
To a mixture of 4 (2.33 g, 10 mmol) and ethyl 
chloroacetate (1.22 g, 10 mol) in dry acetone (20 mL), 
anhydrous potassium carbonate (1.4 g, 10 mol) was 
added and refluxed on a water-bath for 10 h. The 
reaction mixture was washed with water (3×100 mL). 
The organic material was extracted with ether 
(2×100 mL) and left to be evaporated slowly. The 
solid obtained was crystallized from ethanol to furnish 
6 (2.23g, 70%), pale-yellow crystals, m.p.165-167°C. 
IR (KBr): 2900, 2920, 2880 (C-Haliphatic),1659 
(C=Oester), 1615 cm
−1 (C=N); 1H NMR (400 MHZ, 
DMSO-d6): δ 1.25-1.34 (m, 6H, 2CH3-CH2-), 1.90(2H, 
-CH2-CH2-CH3), 1.75 (m, 2H, -CH2Me),4.27 (q, 2H, -
OCH2CH3), 4.78 (s, 2H, O-CH2-C=O), 8.19, 8.38 (m, 
3H, Ar-H); 13C NMR (100 MHZ): δ 164 (C-1), 160 (C-
2), 120.9 (C-3), 128.8 (C-4), 127.4 (C-5), 133.5 (C-6), 
122.4(C-7), 147.1(C-8), 25.6(C-9), 14.6(C-10), 13.9 
(C-11), 65.5(C-12, OCH2), 170 (C-13C=O ester), 28.2(C-
14), 15.5 (C-15); MS: m/z 319 (M+,22), 320 (M+1,38). 
Anal. Calcd for C15H17N3O5 (319): C, 56.42; H, 5.37; 
N, 13.16. Found: C, 56.80; H, 5.80; N, 1350.80%. 
 
3-Hydroxy-6-nitro-2-propylquinazolin-4(3H)-one, 7 
An equimolar mixture of benzoxazinone 3 (2.34 g, 
10 mmol) and hydroxylamine hydrochloride (6.9 g, 




10 mmol) in 20 mL of dry pyridine was heated under 
reflux for 4 h, left to cool and then poured into cold 
water with constant stirring. The solid product that 
separated out was filtered off, thoroughly washed 
with water, dried and then recrystallized from 
benzene to give compound 7 (1.86, 75%), white 
crystals, m.p.230-231°C. IR (KBr): 3530 (OH),1680 
(C=O), 1615 cm−1 (C=N); 1H NMR (400 MHZ, 
DMSO-d6): δ 2.20(2H, -CH2-CH2-CH3), 1.80 (m, 2H, 
-CH2Me), 1.15 (t, 3H, -CH3), 11.20 (bs, 1H 
exchangeable with D2O, O–H), 7.80, 8.10 (m, 3H, Ar-
H, quinazolone); 13C NMR (100 MHZ): δ 164.2 (C-1), 
162.3 (C-2), 131.1 (C-3), 130.7 (C-4), 123.5 (C-5), 
139.4 (C-6), 118.7 (C-7), 149.8 (C-8), 23.0 (C-9), 
13.4 (C-10), 11.6 (C-11); MS: m/z 249 (M+,100),250 
(M+1,12). Anal. Calcd for C11H11N3O4 (249): C, 53.01; 




1 mol of compound 7 (2.49g, 10 mmol) was heated 
under reflux in 30 mL of freshly distilled acetic 
anhydride for 3 h. The reaction solution was left to 
cool and the solid that deposited was filtered off, 
washed several times with light petroleum, dried and 
recrystallized from ethanol to afford the desired 
product 8 (1.9g, 65%), white crystals, m.p.175-177°C. 
IR (KBr): 1669 (C=Oquinazolinone), 1725 (C=Oester), 1614 
cm−1 (C=N); 1H NMR (400 MHZ, DMSO-d6): δ 2.02 
(2H, -CH2-CH2-CH3), 1.68 (m, 2H, -CH2Me), 1.28 (t, 
3H, -CH3), 7.9 (s, 3H, COCH3), 7.80-8.10 (m, 3H, Ar-
H); 13C NMR (100 MHZ): δ 155.2 (C-1), 161 (C-2), 
120 (C-3), 128 (C-4), 127.4 (C-5), 133.5 (C-6), 122 
(C-7), 147 (C-8), 25.1 (C-9), 14.6 (C-10), 13.9 (C-
11), 169.3 (C-12), 18.5 (C-13); MS: m/z 291 
(M+,100), 292 (M+1,12). Anal. Calcd for C13H13N3O5 
(291): C, 53.61; H, 4.50; N, 14.43. Found: C, 53.70; 
H, 4.80; N, 14.90%. 
 
General procedure for formation of synthesis of 
compounds 9a-c 
A magnetically stirred solution of benzoxazinone 3 
(2.34 g, 10 mmol) in glacial acetic acid (20 mL) 
maintained at 100°C was treated with each of o-
phenylendiamine (1.08 g, 10 mmol), o-aminophenol 
(1.09 g, 10 mmol) o-aminothiophenol (1.46 mL, 10 
mmol). The resulting solution was stirred at 100°C for 
additional 4 h before being cooled, poured into water 
(30 mL) and extracted with ethyl acetate (2 × 30 mL). 
The combined organic phases were washed with brine 
(2 × 30 mL) before being dried (Na2SO4), filtered and 
concentrated under reduced pressure. The solid 




4(3H)-one, 9a: 1.94 g, 60%, pale-yellow crystals, 
m.p.164-165°C. IR (KBr): 3360, 3280 (NH2), 3051 
(C–Haromatic), 2920 (C–Haliphatic), 1675 (C=Oquinazolinone), 
1620 cm−1 (C=N); 1H NMR (400 MHZ, DMSO-d6): δ 
2.00 (2H, -CH2-CH2-CH3), 1.70 (m, 2H, -CH2Me), 
1.02 (t, 3H, -CH3), 5.2(s, 2H, D2O-exchangeable, NH2), 
7.21-7.34 (m, 7H, Ar-H); 
13C NMR (100MHz): δ 
164.0 (C-1), 164.8 (C-3), 133.0 (C-3), 131.0 (C-4), 
124.1 (C-5), 135.1 (C-6), 117.5 (C-7), 148.5 (C-8), 
22.1 (C-9), 13.9 (C-10), 11.8 (C-11),, 127.5 (C-12), 
136.8 (C-13), 116.9 (C- 14), 125.9 (C-15), 119.0 (C-
16), 120.0 (C-17); MS: m/z 324 (M+,100), 325 
(M++1,12). Anal. Calcd for C17H16N4O3 (324): C, 62.95; 
H, 4.97; N, 17.27. Found: C, 63.20; H, 5.10; N, 17.40%. 
 
3-(2-Hydroxyphenyl)-6-nitro-2-propylquinazolin-
4(3H)-one, 9b: 2.5 g, 76%, orange crystals, m.p.170-
172°C. IR (KBr): 3360 (OH), 3040 (C–Haromatic), 2929 
(C–Haliphatic), 1680 (C=Oquinazolinone), 1625 cm
−1 (C=N); 
1H NMR (400 MHZ, DMSO-d6): δ 2.20 (2H, -CH2-
CH2-CH3), 1.85 (m, 2H, -CH2Me), 1.12 (t, 3H, -CH3), 
7.22-7.85 (m, 7H, Ar-H), 11.81 (s, 1H, OH 
exchangeable with D2O); 
13C NMR (100MHz): δ 
163.0 (C-1), 164.7 (C-3), 132.4 (C-3), 130.4 (C-4), 
123.3 (C-5), 137.1 (C-6), 118.1 (C-7), 149.5 (C-8), 
23.1 (C-9), 13.4 (C-10), 13.4 (C-11), 127.3 (C-12), 
138.4 (C-13), 115.1 (C- 14), 124.6 (C-15), 118.5 (C-
16), 121.1 (C-17); MS: m/z 325 (M+,60), 326 (M+ + 
1,22). Anal. Calcd for C17H15N3O4 (325): C, 62.76; H, 
4.65; N, 12.92%. Found: C, 62.90; H, 4.80; N, 13.01%. 
 
3-(2-Mercaptophenyl)-6-nitro-2-propylquinazolin-
4(3H)-one, 9c: (1.7 g, 50%), orange crystals, m.p. 
210-211°C. IR (KBr): 3400 (SH), 3030 (C–Haromatic), 
2910 (C–Haliphatic), 1670 (C=Oquinazolinone), 1618 cm
−1 
(C=N); 1H NMR (400 MHZ, DMSO-d6): δ 2.10 (2H, -
CH2-CH2-CH3), 1.75 (m, 2H, -CH2Me), 1.10 (t, 3H, -
CH3), 7.52-7.95 (m, 7H, Ar-H), 12.51 (s, 1H, SH 
exchangeable with D2O; 
13C NMR(100MHz): δ 163.2 
(C-1), 164.1 (C-3), 132.0 (C-3), 130.0 (C-4), 123.1 
(C-5), 136.1 (C-6), 118.5 (C-7), 149.0 (C-8), 22.9 (C-
9), 13.2 (C-10), 11.4 (C-11),, 127.1 (C-12), 136.4 (C-
13), 116.1 (C- 14), 125.6 (C-15), 119.5 (C-16), 120.1 
(C-17); MS: m/z 341 (M+,18),342 (M+ + 1,20). Anal. 
Calcd for C17H15N3O3S (341): C, 59.81; H, 4.43; N, 
12.31. Found: C, 60.00; H, 4.61; N, 12.44%. 




General procedure for formation of synthesis of 
compounds 10a,b 
A mixture of benzoxazinone 3 (2.342 g, 10 mmol) 
and the appropriate urea derivatives, urea (0.60g, 10 
mmol) and/or thiourea (0.76 g, 10 mmol), in DMF 
(20 mL) was refluxed for 4 h. After the completion of 
reaction, the reaction mixture was poured into ice water 
to give a precipitate that was filtered off and 
recrystallized from ethanol to give 10a,b. 
 
6-Nitro-4-oxo-2-propylquinazoline-3(4H)-
carboxamide 10a: 1.66 g, 60%, pale-yellow crystals, 
m.p.180-182°C. IR (KBr): 3300-3240 (NH2), 3050 
(C–Haromatic), 2950 (C–Haliphatic), 1675 
(C=Oquinazolinone), 1640 (C=O), 1618 cm
−1 (C=N); 
1H NMR (400 MHZ, DMSO-d6): δ 1.90 (2H, -CH2-
CH2-CH3), 1.72 (m, 2H, -CH2Me), 1.15 (t, 3H, -CH3), 
4.5 (s, 2H, D2O-exchangeable, NH2), 7.50-7.70 (m, 3H, 
Ar-H); 
13C NMR (100MHz): δ 164 (C-1), 160 (C-2), 
120.9 (C-3), 128.8 (C-4), 127.4 (C-5), 133.5 (C-6), 
122.4(C-7), 147.1(C-8), 25.6(C-9), 14.6(C-10), 13.9 
(C-11), 168(C-12C=ONH2); MS: m/z 276 (M
+,100), 277 
(M+ + 1,12). Anal. Calcd for C12H12N4O4 (276): C, 




carbothioamide10b: 2g, 70%, white crystals, 
m.p.200-201°C. IR (KBr): 3320, 3270 (NH2), 3000 
(C–Haromatic), 2900 (C–Haliphatic), 1671 (C=Oquinazolinone), 
1621 (C=N), 1240 cm−1 (C=S); 1H NMR (400 MHZ, 
DMSO-d6): δ 2.10 (2H, -CH2-CH2-CH3), 1.82 (m, 2H, 
-CH2Me), 1.10 (t, 3H, -CH3), 5.4 (s, 2H, D2O-
exchangeable, NH2), 7.90-8.50 (m, 7H, Ar-H);
 
13C NMR (100MHz): δ 162 (C-1), 161 (C-2), 121.9 
(C-3), 127.5 (C-4), 126.2 (C-5), 131.5 (C-6), 120.4(C-
7), 146.2(C-8), 24.6(C-9), 13.6(C-10), 11.9 (C-11), 
172(C-12C=S); MS: m/z 292 (M
+,32),293 (M+ + 1,18). 
Anal. Calcd for C12H12N4O3S (292): C, 49.31; H, 
4.14; N, 19.17. Found: C, 49.70; H, 14.30; N, 
19.40%. 
 
General procedure for formation of synthesis of 
compounds 11a,b 
An equimolar mixture of benzoxazinone 3 (2.34 g, 
10 mmol) and hydrazine hydrate (0.75 g, 10 mmol) 
and/or phenylhydrazine (1.08 g, 10 mmol), in ethanol 
was heated at refluxing temperature for 4 h. The solid 
that settled down on cooling was filtered off and 
crystallized from light petroleum 60/80 to give 11a,b. 
3-Amino-6-nitro-2-propylquinazolin-4(3H)-one, 
11a: 2.23g, 90%, pale-yellow crystals, m.p.133-134°C. 
IR (KBr): 3309, 3212 (NH2), 3010 (C–Haromatic), 2930 
(C–Haliphatic), 1673 (C=Oquinazolinone), 1620 cm
−1 (C=N); 
1H NMR (400 MHZ, DMSO-d6): δ 2.20 (2H, -CH2-
CH2-CH3), 1.80 (m, 2H, -CH2Me), 1.15 (t, 3H, -CH3), 
5.50 (s, 2H, D2O-exchangeable, NH2), 7.20-7.80 (m, 
3H, Ar-H);
 13C NMR (100MHz): δ 163.5 (C-1), 167.1 
(C-2), 129.2 (C-3), 131.7 (C-4), 121.5 (C-5), 136.7 (C-
6), 124.3 (C-7), 146.4 (C-8), 23.0 (C-9), 13.4 (C-10), 
12.6 (C-11); MS: m/z 248 (M+,100), 249 (M+ + 1,12). 
Anal. Calcd for C11H12N4O3 (248): C, 53.22; H, 4.87; 
N, 22.57. Found: C, 53.55; H, 4.95; N, 22.90%. 
 
6-Nitro-3-(phenylamino)-2-propylquinazolin-4(3H)-
one, 11b: 2.75g, 85%, pale-yellow crystals, m.p.192-
193°C. IR (KBr): 3385 (NH), 3000 (C–Haromatic), 2910 
(C–Haliphatic), 1675 (C=Oquinazolinone), 1622 cm
−1 (C=N); 
1H NMR (400 MHZ, DMSO-d6): δ 2.10 (2H, -CH2-
CH2-CH3), 1.70 (m, 2H, -CH2Me), 1.10 (t, 3H, -CH3), 
8.90 (bs, 1H exchangeable with D2O, N–H), 7.50-8.80 
(m, 8H, Ar-H); 
13C NMR (100MHz): δ 163.1 (C-1), 
166.9 (C-2), 129.2 (C-3), 131.8 (C-4), 121.5 (C-5), 
136.1 (C-6), 124.0 (C-7), 146.2 (C-8), 23.1 (C-9), 13.4 
(C-10), 12.3 (C-11), 136.0 (C-12), 130.1 (C- 13), 128.4 
(C-14), 132.1 (C-15), 128.4 (C-16), 130.1 (C-17); MS: 
m/z 324 (M+,100), 325 (M+ + 1,12). Anal. Calcd for 
C17H16N4O3 (324): C, 62.95; H, 4.97; N, 17.27. Found: 




A solution of 11 (2.48 g, 10 mmol) and acetic 
anhydride (20 mmol) in glacial acetic acid (30 mL) was 
heated at refluxing temperature for 4 h. When the 
reaction mixture was left to cool and diluted with cold 
water, the solid which separated out was filtered off 
and recrystallized from ethanol to afford 12 (2 g, 70%), 
yellow crystals, m.p.170-172°C. IR (KBr): 3487 (OH), 
3280 (NH), 3080 (C–Harom), 2910 (C–Haliph), 1673 
(C=Oquinazolinone), 1635 (C=Oamidic) 1610 cm
−1 (C=N); 
1H NMR (400 MHZ, DMSO-d6): δ 2.30 (2H, -CH2-
CH2-CH3), 2.00 (2, 3H, CH3-C=O), 1.70 (m, 2H, -
CH2Me), 1.30 (t, 3H, -CH3), 8.00-7.85 (m, 3H, Ar-H), 
6.50 (bs, 1H exchangeable with D2O, NH), 8.90 (bs, 
1H exchangeable with D2O, OH);
 13C NMR (100 
MHz): δ 155.2 (C-1), 161 (C-2), 120 (C-3), 128 (C-4), 
127.4 (C-5), 133.5 (C-6), 122 (C-7), 147 (C-8), 25.1 
(C-9), 14.6 (C-10), 13.9 (C-11), 173.0 (C-12 NHCO), 
12.0 (C-13COCH3); MS: m/z 290 (M
+,100), 291 (M+ + 




1, 12). Anal. Calcd for C13H14N4O4 (290): C, 53.79; H, 




An aqueous solution of sodium hydroxide (12 mL, 
24 mmol, 2 N) was drop-wise added to a stirred 
mixture of the amine 11 (2.48 g, 10 mmol) and carbon 
disulfide (1.5 mL, 24 mmol), in DMSO (20 mL), in 
an ice bath, over a period of 30 min. Then the reaction 
mixture was stirred for additional 3 h. Afterwards, 
dimethyl sulphate (1.9 mL, 20 mmol) was gradually 
added with continuous stirring in 2 h. Then the 
reaction mixture was diluted with ice-cold water 
(40 mL) to give solid deposits which were filtered, 
washed with water, dried and crystallized from 
acetonitrile to yield compound 13 (2 g, 60%), yellow 
crystals, m.p.145-146°C. IR (KBr): 3280, 3150 (N–
H), 3060 (C– Haromatic), 2980, 2900, 2870 (C–Haliphatic), 
1670 (C=O), 1610 (C=N, N–H), 1450 cm−1 (C=S); 
1H NMR (400 MHZ, DMSO-d6): δ 2.50 (s, 3H, SCH3), 
2.10 (2H, -CH2-CH2-CH3), 1.65 (m, 2H, -CH2Me), 
1.15 (t, 3H, -CH3), 7.20-7.80 (m, 3H, Ar-H), 9.95 (bs, 
1H exchangeable with D2O, N–H); 
13C NMR (100 
MHz): δ 155.2 (C-1), 161 (C-2), 120 (C-3), 128 (C-4), 
127.4 (C-5), 133.5 (C-6), 122 (C-7), 147 (C-8), 25.1 
(C-9), 14.6 (C-10), 13.9 (C-11), 179.3 (C-12CS), 12.2 
(C-13 SCH3); MS: m/z 338 (M
+,100), 339 (M+ + 1, 
12). Anal. Calcd for C13H14N4O3S2 (338): C, 46.14; H, 





A mixture of 11 (2.48 g, 10mol) and benzaldehyde 
(0.01 mol) in 60 mL of ethanol, containing a few 
drops of piperidine as a catalyst, was refluxed for 4h. 
The solid separated out upon cooling was filtered off 
and recrystallized from benzene to produce compound 
14 (2.7g, 80%), white crystals, m.p.180-181°C. IR 
(KBr): 3020 (C– Haromatic),2900(C–Haliphatic), 161676 
(C=O), 1610 cm−1 (C=N); 1H NMR (400 MHZ, 
DMSO-d6): δ 2.20 (2H, -CH2-CH2-CH3), 1.85 (m, 2H, 
-CH2Me), 1.10 (t, 3H, -CH3), 7.40-8.20 (m, 8H, Ar-
H), 8.80 (s, 1H, N=CH);
 13C NMR (100 MHz): δ 
163.1 (C-1), 166.9 (C-2), 129.2 (C-3), 131.8 (C-4), 
121.5 (C-5), 136.1 (C-6), 124.0 (C-7), 146.2 (C-8), 
23.1 (C-9), 13.4 (C-10), 13.4 (C-11), 164.5(C-12C=N), 
136.0 (C-13), 130.1 (C- 14), 128.4 (C-15), 132.1 (C-
16), 128.4 (C-17), 130.1 (C-18); MS: m/z 336 
(M+,100), 337 (M+ +1,18). Anal. Calcd for 
C18H16N4O3 (336): C, 64.28; H, 4.79; N, 16.66. 
Found: C, 64.30; H, 4.90; N, 16.90%. 
 
Conclusion 
The current study established new chemosensors 
quinazolinones 9a and 11 for the quantitative 
determination of Cu2+, Cd2+ at exact wavelengths in 
an aqueous medium and in blood samples. Similarly, 
chemosensors 10b and 7 have been synthesized for 
determination of Hg2+ ion in an aqueous medium and 
the environmental samples like water samples. Hence, 
we designed a paper strip carrying chemosensor, so 
the determination of Cu2+, Cd2+ and Hg2+ will become 
easy and inexpensive. 
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